BACKGROUND: Increasing affordability of artemisinin combination therapy (ACT) in the African retail sector could be critical to expanding access to effective malaria treatment, but must be balanced by efforts to protect the efficacy of these drugs. Previous research estimates ACT adherence rates among public sector patients, but adherence among retail sector purchasers could differ substantially. This study aimed to estimate adherence rates to subsidized, over-the-counter ACT in rural Uganda. METHODS: An intervention study was conducted with four licensed drug shops in Eastern Uganda in December 2009. Artemether-lumefantrine (AL) was made available for sale at a 95% subsidy over-the counter. Customers completed a brief survey at the time of purchase and then were randomly assigned to one of three study arms: no follow-up, follow-up after two days or follow-up after three days. Surveyors recorded the number of pills remaining through blister pack observation or through self-report if the pack was unavailable. The purpose of the three-day follow-up arm was to capture non-adherence in the sense of an incomplete treatment course ("under-dosing"). The purpose of the two-day follow-up arm was to capture whether participants completed the full course too soon ("over-dosing"). RESULTS: Of the 106 patients in the two-day follow-up sample, 14 (13.2%) had finished the entire treatment course by the second day. Of the 152 patients in the three-day follow-up sample, 49 (32.2%) were definitely non-adherent, three (2%) were probably non-adherent and 100 (65.8%) were probably adherent. Among the 52 who were non-adherent, 31 (59.6%) had more than a full day of treatment remaining. CONCLUSIONS: Overall, adherence to subsidized ACT purchased over-the-counter was found to be moderate. Further, a non-trivial fraction of those who complete treatment are taking the full course too quickly. Strategies to increase adherence in the retail sector are needed in the context of increasing availability and affordability of ACT in this sector.
RCT Entities:
BACKGROUND: Increasing affordability of artemisinin combination therapy (ACT) in the African retail sector could be critical to expanding access to effective malaria treatment, but must be balanced by efforts to protect the efficacy of these drugs. Previous research estimates ACT adherence rates among public sector patients, but adherence among retail sector purchasers could differ substantially. This study aimed to estimate adherence rates to subsidized, over-the-counter ACT in rural Uganda. METHODS: An intervention study was conducted with four licensed drug shops in Eastern Uganda in December 2009. Artemether-lumefantrine (AL) was made available for sale at a 95% subsidy over-the counter. Customers completed a brief survey at the time of purchase and then were randomly assigned to one of three study arms: no follow-up, follow-up after two days or follow-up after three days. Surveyors recorded the number of pills remaining through blister pack observation or through self-report if the pack was unavailable. The purpose of the three-day follow-up arm was to capture non-adherence in the sense of an incomplete treatment course ("under-dosing"). The purpose of the two-day follow-up arm was to capture whether participants completed the full course too soon ("over-dosing"). RESULTS: Of the 106 patients in the two-day follow-up sample, 14 (13.2%) had finished the entire treatment course by the second day. Of the 152 patients in the three-day follow-up sample, 49 (32.2%) were definitely non-adherent, three (2%) were probably non-adherent and 100 (65.8%) were probably adherent. Among the 52 who were non-adherent, 31 (59.6%) had more than a full day of treatment remaining. CONCLUSIONS: Overall, adherence to subsidized ACT purchased over-the-counter was found to be moderate. Further, a non-trivial fraction of those who complete treatment are taking the full course too quickly. Strategies to increase adherence in the retail sector are needed in the context of increasing availability and affordability of ACT in this sector.
Authors: Kimberly E Mace; Dyson Mwandama; James Jafali; Madalitso Luka; Scott J Filler; John Sande; Doreen Ali; S Patrick Kachur; Don P Mathanga; Jacek Skarbinski Journal: Clin Infect Dis Date: 2011-10 Impact factor: 9.079
Authors: Carole Fogg; Francis Bajunirwe; Patrice Piola; Samuel Biraro; Francesco Checchi; James Kiguli; Proscovia Namiiro; Joy Musabe; Agnes Kyomugisha; Jean-Paul Guthmann Journal: Am J Trop Med Hyg Date: 2004-11 Impact factor: 2.345
Authors: S Patrick Kachur; Rashid A Khatib; Ellen Kaizer; Susan S Fox; Salim M Abdulla; Peter B Bloland Journal: Am J Trop Med Hyg Date: 2004-12 Impact factor: 2.345
Authors: Eline L Korenromp; Brian G Williams; Eleanor Gouws; Christopher Dye; Robert W Snow Journal: Lancet Infect Dis Date: 2003-06 Impact factor: 25.071
Authors: Alexander M Jacobine; Jennifer R Mazzone; Rachel D Slack; Abhai K Tripathi; David J Sullivan; Gary H Posner Journal: J Med Chem Date: 2012-08-27 Impact factor: 7.446
Authors: Georgia R Gore-Langton; Nfornuh Alenwi; James Mungai; Nahashon I Erupe; Katie Eves; Francis Njoroge Kimwana; David Soti; Willis Akhwale; Farah A Hassan; Elizabeth Juma; Richard Allan Journal: Malar J Date: 2015-03-24 Impact factor: 2.979
Authors: Ahmad M Yakasai; Muhammad Hamza; Mahmood M Dalhat; Musa Bello; Muktar A Gadanya; Zuwaira M Yaqub; Daiyabu A Ibrahim; Fatimah Hassan-Hanga Journal: J Trop Med Date: 2015-05-28
Authors: Ambrose O Talisuna; Seraphine Adibaku; Chioma N Amojah; George K Amofah; Vivian Aubyn; Alex Dodoo; Elizabeth Juma; Djermakoye H Jackou; Sigsbert Mkude; Albert P Okui; Benjamin Ramarosandratana; Shija J Shija Journal: Malar J Date: 2012-11-08 Impact factor: 2.979
Authors: Ambrose O Talisuna; Penny Grewal Daumerie; Andrew Balyeku; Timothy Egan; Bram Piot; Renia Coghlan; Maud Lugand; Godfrey Bwire; John Bosco Rwakimari; Richard Ndyomugyenyi; Fred Kato; Maria Byangire; Paul Kagwa; Fred Sebisubi; David Nahamya; Angela Bonabana; Susan Mpanga-Mukasa; Peter Buyungo; Julius Lukwago; Allan Batte; Grace Nakanwagi; James Tibenderana; Kinny Nayer; Kishore Reddy; Nilesh Dokwal; Sylvester Rugumambaju; Saul Kidde; Jaya Banerji; George Jagoe Journal: Malar J Date: 2012-10-29 Impact factor: 2.979
Authors: David Sears; Ruth Kigozi; Arthur Mpimbaza; Stella Kakeeto; Asadu Sserwanga; Sarah G Staedke; Michelle Chang; Bryan K Kapella; Denis Rubahika; Moses R Kamya; Grant Dorsey Journal: Malar J Date: 2013-07-19 Impact factor: 2.979